Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Genetic Services Laboratory University of Chicago United States | 72 | 133 |
|
NDE1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
PreventionGenetics, part of Exact Sciences United States | 29 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 79 | 52 |
|
Lissencephaly-4 with Microcephaly via the NDE1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Lissencephaly core Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 11 | 10 |
|
Lissencephaly core Deletion / Duplication test HNL Genomics Connective Tissue Gene Tests United States | 11 | 10 |
|
Lissencephaly and related disorders Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 46 | 42 |
|
Lissencephaly and related disorders Deletion / Duplication test HNL Genomics Connective Tissue Gene Tests United States | 46 | 42 |
|
Comprehensive Brain Malformation Panel Genetic Services Laboratory University of Chicago United States | 37 | 131 |
|
Comprehensive Brain Malformations Panel GeneDx United States | 19 | 103 |
|
Fulgent Genetics United States | 509 | 275 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Cerebral Cortical Malformation NGS Panel Fulgent Genetics United States | 210 | 42 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics Inc United States | 233 | 234 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Developmental Brain Malformations Athena Diagnostics Inc United States | 43 | 40 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.